Changes in Breast 3D Ultrasound Measurements Using Toremifene

Volume and Circulation Changes of The Breast in 3D Ultrasound During Toremifene Versus Nonmedicated Menstrual Cycle

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01417754

Enrollment

Registered

2011-08-16

Start date

2010-09-30

Completion date

2011-06-30

Last updated

2011-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory; Change

Keywords

toremifene

Brief summary

To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.

Detailed description

20 women were participated to this trial.

Interventions

DRUGToremifene

20mg toremifene per day in tablet form starting from the cycle day 15 and continued to premenstrual period. Medication using about 10 days per volunteer

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* age 25-45 healthy person * regular menstrual cycles * safe contraception(for example sterilization or condom)

Exclusion criteria

* gynecological or other type of cancer * hormonal contraception * pregnancy

Design outcomes

Primary

Measure	Time frame
circulation changes of the breast	cycle day 23 to 26

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026